EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcatheter Aortic Valve Replacement in Degenerated Perceval Bioprosthesis: Clinical and Technical Aspects in 32 Cases

Giovanni Concistrè, Tommaso Gasbarri iD, Marcello Ravani, Anees Al Jabri, Giuseppe Trianni, Giacomo Bianchi iD, Rafik Margaryan iD, Francesca Chiaramonti, Michele Murzi, Enkel Kallushi, Egidio Varone, Simone Simeoni und 4 weitere

Journal of Clinical Medicine · 28.09.2023 · 12 (19) · 6265

DOI: 10.3390/jcm12196265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.09.2023. Verfasst von Giovanni Concistrè und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Cardiac Surgery, G. Pasquinucci Heart Hospital, Fondazione CNR-G. Monasterio, 54100 Massa, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sutureless aortic bioprostheses are increasingly being used to provide shorter cross-clamp time and facilitate minimally invasive aortic valve replacement. As the use of sutureless valves has increased over the past decade, we begin to encounter their degeneration. We describe clinical outcomes and technical aspects in patients with degenerated sutureless Perceval (CorCym, Italy) aortic bioprosthesis treated with valve-in-valve transcatheter aortic valve replacement (VIV-TAVR).

Methods

Between March 2011 and March 2023, 1310 patients underwent aortic valve replacement (AVR) with Perceval bioprosthesis implantation. Severe bioprosthesis degeneration treated with VIV-TAVR occurred in 32 patients with a mean of 6.4 ± 1.9 years (range: 2–10 years) after first implantation. Mean EuroSCORE II was 9.5 ± 6.4% (range: 1.9–35.1%).

Results

Thirty of thirty-two (94%) VIV-TAVR were performed via transfemoral and two (6%) via transapical approach. Vascular complications occurred in two patients (6%), and mean hospital stay was 4.6 ± 2.4 days. At mean follow-up of 16.7 ± 15.2 months (range: 1–50 months), survival was 100%, and mean transvalvular pressure gradient was 18.7 ± 5.3 mmHg.

Conclusion

VIV-TAVR is a useful option for degenerated Perceval and appears safe and effective. This procedure is associated with good clinical results and excellent hemodynamic performance in our largest single-center experience.

Schlagwörter

Stichwörter der Autor:innen

aortic bioprosthesis degenerationaortic valve replacementsutureless aortic valvetranscatheter aortic valve

Autor:innen und Institutionen

  • Department of Adult Cardiac Surgery, G. Pasquinucci Heart Hospital, Fondazione CNR-G. Monasterio, 54100 Massa, Italy.
  • Department of Cardiology, G. Pasquinucci Heart Hospital, Fondazione CNR-G. Monasterio, 54100 Massa, Italy.

ORCID-Profile: Tommaso Gasbarri, Giacomo Bianchi, Rafik Margaryan, Sergio Berti

Zitieren

APA

Concistrè, G., Gasbarri, T., Ravani, M., Al Jabri, A., Trianni, G., Bianchi, G., Margaryan, R., Chiaramonti, F., Murzi, M., Kallushi, E., Varone, E., Simeoni, S., Leone, A., Farneti, A., Berti, S., & Solinas, M. (2023). Transcatheter Aortic Valve Replacement in Degenerated Perceval Bioprosthesis: Clinical and Technical Aspects in 32 Cases. Journal of Clinical Medicine, 12(19), 6265. https://doi.org/10.3390/jcm12196265

Vancouver

Concistrè G, Gasbarri T, Ravani M, Al Jabri A, Trianni G, Bianchi G, et al. Transcatheter Aortic Valve Replacement in Degenerated Perceval Bioprosthesis: Clinical and Technical Aspects in 32 Cases. Journal of Clinical Medicine. 2023;12(19):6265. doi:10.3390/jcm12196265

BibTeX
@article{Concistr2023,
  author = {Concistrè, Giovanni and Gasbarri, Tommaso and Ravani, Marcello and Al Jabri, Anees and Trianni, Giuseppe and Bianchi, Giacomo and Margaryan, Rafik and Chiaramonti, Francesca and Murzi, Michele and Kallushi, Enkel and Varone, Egidio and Simeoni, Simone and Leone, Alessandro and Farneti, Andrea and Berti, Sergio and Solinas, Marco},
  title = {Transcatheter Aortic Valve Replacement in Degenerated Perceval Bioprosthesis: Clinical and Technical Aspects in 32 Cases},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {19},
  pages = {6265},
  doi = {10.3390/jcm12196265}
}
Kostenlos starten →